The present application is for new funding of a program project grant on the Pathogenesis and Prevention of Autoimmune Diabetes. The purpose of this funding is to allow four investigators who have worked together in the past to continue to do in the future. The program consists of four projects supported by three cores. the projects are as follows: Project 1: C.A. Janeway, PI. This project focuses on CD8 T cells that can transfer acute diabetes to NOD mice. These CD8 cloned T cells lines enter the islets in three hours and cause diabetes in all mice tested. We will study their homing, construct a TCR transgenic mouse, and identify the beta cell antigen they detect. Project 2: R.A. Flavell, PI. This project is designed to analyze tolerance in models using normal and NOD transgenic mice, to ask if there is a generalized defecting tolerance in the NOD mice, and to determine its mechanism. Project 3: A.C. Hayday, PI. This project will examine the role of the autoantigen glutamic acid decarboxylase (GAD) in NOD mice. We have observed strong promotion of insultis and some increase in diabetes in these mice.
The aim of the project is to study this acceleration, using TCR transgenes specific for GAD. Project 4: RS.Sherwin, PI. This project is mainly focused on the characterization of insulin-specific protective T cell clones. Their mechanism of action and their development will be characterized using TCR transgenics, hopefully leading to a vaccine. The four projects are supported by three core facilities: Core A, Administrative Core, C. Janeway PI; Core B, Animal core, Fs. Wong, PI; Core C, Islet Isolation and Imunohistopathology Core, M. Solimena, PI.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
3P01DK053015-01S1
Application #
2730330
Study Section
Special Emphasis Panel (ZDK1 (M1))
Program Officer
Akolkar, Beena
Project Start
1997-09-30
Project End
2002-11-30
Budget Start
1997-09-30
Budget End
1998-11-30
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Yale University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Bonner, Samantha M; Pietropaolo, Susan L; Fan, Yong et al. (2012) Sequence variation in promoter of Ica1 gene, which encodes protein implicated in type 1 diabetes, causes transcription factor autoimmune regulator (AIRE) to increase its binding and down-regulate expression. J Biol Chem 287:17882-93
Kim, Sunshin; Millet, Isabelle; Kim, Hun Sik et al. (2007) NF-kappa B prevents beta cell death and autoimmune diabetes in NOD mice. Proc Natl Acad Sci U S A 104:1913-8
Kriegel, Martin A; Li, Ming O; Sanjabi, Shomyseh et al. (2006) Transforming growth factor-beta: recent advances on its role in immune tolerance. Curr Rheumatol Rep 8:138-44
Millet, I; Wong, F S; Gurr, W et al. (2006) Targeted expression of the anti-apoptotic gene CrmA to NOD pancreatic islets protects from autoimmune diabetes. J Autoimmun 26:7-15
Du, Wei; Wong, F Susan; Li, Ming O et al. (2006) TGF-beta signaling is required for the function of insulin-reactive T regulatory cells. J Clin Invest 116:1360-70
Li, Ming O; Wan, Yisong Y; Sanjabi, Shomyseh et al. (2006) Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24:99-146
Wen, L; Wong, F S (2005) How can the innate immune system influence autoimmunity in type 1 diabetes and other autoimmune disorders? Crit Rev Immunol 25:225-50
Wong, F Susan; Wen, Li; Tang, Michelle et al. (2004) Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes 53:2581-7
Eshima, Koji; Mora, Conchi; Wong, F Susan et al. (2003) A crucial role of CD4 T cells as a functional source of CD154 in the initiation of insulin-dependent diabetes mellitus in the non-obese diabetic mouse. Int Immunol 15:351-7
Rajagopalan, Govindarajan; Kudva, Yogish C; Flavell, Richard A et al. (2003) Accelerated diabetes in rat insulin promoter-tumor necrosis factor-alpha transgenic nonobese diabetic mice lacking major histocompatibility class II molecules. Diabetes 52:342-7

Showing the most recent 10 out of 27 publications